Neurolytic Healthcare Study

Migraine affects 1 in 6 people worldwide, and yet the typical patient takes over a year to get the right medication. This is largely due to the trial-and-error nature of migraine treatment prescription.
The N-Health companion app is part of the Neurolytic Healthcare Migraine Study - the world's first biomarker informed migraine study.
With this study we hope to be able to optimise treatment decision making on a patient by patient basis, making sure that everyone who has migraine gets the right therapy.
The Neurolytic Healthcare Study app makes use of digital biomarkers collected through either FitBit or through Apple Healthkit.